Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2020/01/022661
CTRI/2020/01/022661
Not yet recruiting
Phase 2

An open label clinical trial to evaluate the efficacy of Pachmeena Tonic in Ajeerna (Indigestion). - PTI

Multani Pharmaceuticals Ltd0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Multani Pharmaceuticals Ltd
Status
Not yet recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Multani Pharmaceuticals Ltd

Eligibility Criteria

Inclusion Criteria

  • •1\. Subjects suffering from Ajeerna (Indigestion) and its related signs and symptoms such as fullness, bloating, nausea, gassy discomfort, loss of appetite, spasm and pain in the chest or abdomen for at least on two occasions in the preceding week and having normal hepatic and renal functions (LFT \& RFT).

Exclusion Criteria

  • •1\. Subjects with persistent dyspepsia, vomiting, severe epigastric pain unintentional weight loss, iron deficiency anemia, gastro\-intestinal bleeding, dysphasia, odynophagia, previous gastric surgery, epigastric mass, suspicious barium meal, peptic ulcer, and NSAID use.
  • •2\. Organic deformity or malignancy of the GI tract, significant systemic and psychological condition (s) which may hamper the study proceedings, conditions requiring immediate surgical intervention, Alcohol or drug abuse, pregnancy and lactating women.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
Management of Hair Fall through Rovaan Poshaka TailaHealth Condition 1: L639- Alopecia areata, unspecified
CTRI/2020/01/022718Multani Pharmaceuticals Ltd50
Not yet recruiting
Not Applicable
To evaluate the efficacy of medicated enema therapy and external oleation therapy followed by oral medication in the management of hip joint pain.
CTRI/2024/07/070233ational Institute of Ayurveda
Unknown
Phase 2
Management Madhumeha (Diabetes mellitus type 2)
CTRI/2020/01/022662Multani Pharmaceuticals Ltd
Not yet recruiting
Not Applicable
Management Of Klaibya With Special Reference To Erectile Dysfunctio
CTRI/2024/07/070748ational institute of ayurveda
Not yet recruiting
Phase 3
An open label clinical trial to evaluate the efficacy of Vamana Karma ( Emesis) in the management of Urdhwaga Amalpitta (Hyperacidity and Gastritis ).â??Health Condition 1: K290- Acute gastritis
CTRI/2023/03/050890Shri Krishna Government Ayurvedic College and Hospital kurukshetra